RE: Good Morning4 Dec 2025 08:23
Good morning all,
It’s worth pausing to remind ourselves of a simple truth: none of us outside the Board of Directors have any concrete knowledge of potential deals, partnerships, or negotiations at ImmuPharma.
• 📌 Speculation vs. fact: Forums thrive on speculation, but speculation is not information. Unless it comes via an RNS or official company communication, it’s just noise.
• 📌 The information gap: Retail holders, analysts, and even institutional investors are in the dark until the BOD chooses to disclose. That’s how market rules work.
• 📌 Authority rests with the BOD: Only the Board knows the status of any discussions. They are legally bound to keep material developments confidential until disclosure is required.
• 📌 Why this matters: Rumours can mislead, inflate expectations, or cause unnecessary panic. Staying grounded protects both our portfolios and the integrity of the community.
So while it’s natural to speculate, let’s keep perspective: we don’t know, and we won’t know until the company tells us. Anything else is theatre.
So whether it's a 20p, 80p or £20.00 deal at the moment it is where it is - all we can do is put our trust in the PPL negotiating the best deal for the PIs.
OSD - Who sent all this rain over here !!!